MedPath

Evaluation of siddha trial drug Sengatharipattai kudineer(internal) and Murungai pushpam ennai (external) for Balakarappan (Atopic dermatitis)

Phase 2
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2020/11/029181
Lead Sponsor
Government Siddha Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Itching & Scratching

Erythema

Papules with edema

Vesicles

Oozing

Crusthing

Scaling

Lichenification

Exclusion Criteria

Scabies

Photo dermatitis

Ichthyosis

Pitriyasis alba

Cheillitis

Psoriasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in EASI Score <br/ ><br>Reduction in clinical Symptoms <br/ ><br>Photos evidence before and after treatmentTimepoint: 21 days
Secondary Outcome Measures
NameTimeMethod
Comparing Safety parameters before and after treatmentTimepoint: 21 days
© Copyright 2025. All Rights Reserved by MedPath